OakChart

Turn Therapeutics Inc

TTRXHealthcare·Biotechnology·USA·Small·NASD·Nov 11 • 3:59 PM ET

10.57+0.65 (6.55%)
2026-11-12 06:11 CET
Market cap
322.73 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-12.77 USD m
Free cash flow, TTM
-5.28 USD m
EPS diluted, TTM
-0.43
P/E
-
Compare

Price

TTRX against its 20, 50 and 200-day averages
2050200miss
5.0010.0015.00463K925KVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26TTRXclose 10.5720-day 10.2550-day 11.72200-day 7.2010.5752w high

35.7% under the 52-week high of 16.45 on 18 Sep 2026. 52-week low 2.57 on 20 Nov 2025. Last 15 sessions, 40.9% high to low

Volume 0.51× normal · the line is the 50-bar volume average

Profile

TTRX
52-week range, 58% of the way up
2.5716.45

Turn Therapeutics, Inc. is a pharmaceutical and medical device development company. Its primary development programs focus on dermatological diseases. The company was founded by Bradley Burnam on January 6, 2015 and is headquartered in Westlake Village, CA.

Employees2
IPOOct 08, 2025
Beta2.15
ATR, 14d1.03
Rel volume0.51
Short float4.79%
Insider own63.78%
Inst own4.47%

Snapshot

6 groups

Valuation

Index-
Market Cap323.15M
Enterprise Value319.02M
Income-12.77M
Sales0.00M
Book/sh0.19
Cash/sh0.34
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees2
IPOOct 08, 2025

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B56.70
P/C31.19
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio3.01
Current Ratio3.01
Debt/Eq1.09
LT Debt/Eq1.01
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.43
EPS next Y-0.41
EPS next Q-0.12
EPS this Y-300.00%
EPS next Y13.89%
EPS next 5Y-
EPS past 3/5Y29.26% -
Sales past 3/5Y- -
EPS Y/Y TTM-222.21%
Sales Y/Y TTM-
EPS Q/Q-204.12%
Sales Q/Q-
EarningsNov 09 BMO
EPS/Sales Surpr.-142.21% -

Ownership

Insider Own63.78%
Insider Trans0.00%
Inst Own4.47%
Inst Trans16.15%
ROA-123.41%
ROE-408.79%
ROIC-111.72%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA203.15%
SMA50-9.82%
SMA20046.82%
Trades-

Technical

Shs Outstand30.53M
Shs Float11.07M
Short Float4.79%
Short Ratio4.73
Short Interest0.53M
52W High16.45 -35.74%
52W Low2.57 311.27%
Volatility14.70% 9.36%
ATR (14)1.03
RSI (14)50.07
Beta2.15
Rel Volume0.51
Avg Volume112.25K
Volume56,984

Performance

Perf Week7.86%
Perf Month-0.28%
Perf Quarter7.20%
Perf Half Y163.59%
Perf YTD168.27%
Perf Year172.42%
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recom1.67
Target Price20.00
Prev Close9.92
Price10.57
Change %6.55%

Analyst ratings

latest 1 of 1
DateActionAnalystRating changeTargetImplied
Dec 29, 2025InitiatedDD. Boral CapitalBuy$8-24.3%

Peers

Mkt cap
TickerCompanyMkt cap
VRCAVerrica Pharmaceuticals Inc67.17M
PTHSPelthos Therapeutics Inc36.92M
SLGLSol-Gel Technologies Ltd207.57M
SMTISanara MedTech Inc290.43M
ARQTArcutis Biotherapeutics Inc3.59B
MDXGMimedx Group Inc484.47M
ACRSAclaris Therapeutics Inc688.38M
DERMJourney Medical Corp125.31M
DRMADermata Therapeutics Inc3.54M
KRYSKrystal Biotech Inc9.15B

Insider trading

6 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Chaudhary ZuraizSee RemarksDec 12 '25Buy3.502,5008,75012,500Dec 12 06:00 PM
GOLDEN ARTHUR FDirectorNov 24 '25Buy3.449,86833,94660,602Nov 25 09:00 PM
GOLDEN ARTHUR FDirectorNov 21 '25Buy2.8720,53258,92750,734Nov 24 07:13 AM
Chaudhary ZuraizSee RemarksNov 20 '25Buy2.611,4503,7849,000Nov 21 05:43 PM
Chaudhary ZuraizSee RemarksNov 21 '25Buy3.291,0003,29010,000Nov 21 05:43 PM
Chaudhary ZuraizSee RemarksNov 17 '25Buy3.622,5009,0507,550Nov 17 09:23 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWCiShares Micro-Cap ETFAUM: 1.22B
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 111.21M

News

latest 14 of 70

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-09-0.210-0.087-0.2000.000.003
2026Q22026-08-12-0.200-0.020-0.1960.00-1
2026Q12026-05-11-0.030-0.020-0.033--1
2025Q42026-03-31-0.062-0.0510.010--2
2025Q32025-12-03-0.070--0.068---
2026Q4---0.120--0.253
2027Q1---0.050---1
2027Q2---0.110---1
2027Q3---0.080---1
2027Q4---0.120---1
2028Q1---0.042---1
2028Q2---0.040---1
2028Q3---0.043---1
2028Q4---0.048---1

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2025FY-0.120-0.145-0.1300.000.00
2026FY--0.480--0.30
2027FY--0.413--3.37
2028FY--0.500--6.00
2029FY--0.820--15.00
2030FY--0.925--24.96

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-092000.250.000.50
2026Q4S2026-09-232000.250.000.50
2026Q4S2026-08-131000.500.500.50
2026Q4S2026-07-171000.500.500.50
2026Q4R2026-11-09100-0.08-0.08-0.08
2026Q4R2026-10-27100-0.08-0.08-0.08
2026Q4R2026-08-13101-0.08-0.08-0.08
2026Q4R2026-07-17100-0.01-0.01-0.01
2026Q4R2026-05-12110-0.02-0.02-0.02
2026Q4R2026-04-01100-0.03-0.03-0.03
2026Q4R2025-12-26100-0.03-0.03-0.03
2026Q4E2026-11-09300-0.12-0.20-0.08
2026Q4E2026-10-27300-0.12-0.20-0.08
2026Q4E2026-09-23301-0.12-0.20-0.08

Estimate history

EPS, annual-0.325-0.173-0.132-0.115-0.4266
Period2022202320242025TTM
EPS, quarterly-0.011-0.09-0.0680.01-0.033-0.196-0.207
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual00000
Period2022202320242025TTM
Sales, quarterly0000000
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual13.17513.24713.42329.44530.533
Period2022202320242025MRQ
Shares, quarterly29.44514.01128.02329.44529.78829.78830.533
PeriodQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY
Total Revenue0.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.060.050.050.040.05
Gross Profit-0.06-0.05-0.05-0.04-0.05
Selling, General and Administrative Excl. Other6.995.811.752.264.16
Research and Development1.220.270.250.010.00
Other Operating Expense0.000.000.000.000.00
Operating Income-7.05-5.86-1.80-2.31-4.21
Interest Expense-0.000.000.000.09
Unusual Expense3.03-2.960.000.000.00
Net Income Before Taxes-12.77-3.19-1.77-2.29-4.29
Income Taxes0.000.000.000.000.00
Consolidated Net Income-12.77-3.19-1.77-2.29-4.29
Net Income From Continuing Operations-12.77-3.19-1.77-2.29-4.29
Net Income-12.77-3.19-1.77-2.29-4.29
EPS (Recurring)-0.35-0.19-0.13-0.17-0.33
EPS (Basic, Before Extraordinaries)-0.43-0.12-0.13-0.17-0.33
EPS (Diluted)-0.43-0.12-0.13-0.17-0.33
EBITDA-6.99-5.81-1.75-2.26-4.16
Non-Operating Income (Expense)-2.11-0.290.030.020.01
Other After Tax Adjustments0.000.000.000.000.00
Stock Option Compensation Expense1.670.100.350.641.48
Shares Outstanding30.5329.4513.4213.2513.18
Market Capitalization322.73322.73109.24--

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q1
Total Revenue0.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.010.010.010.010.010.000.01
Gross Profit-0.01-0.01-0.01-0.01-0.010.00-0.01
Selling, General and Administrative Excl. Other1.971.611.232.181.901.370.37
Research and Development0.610.480.110.030.160.060.01
Other Operating Expense0.000.000.000.000.000.000.00
Operating Income-1.98-1.63-1.25-2.19-1.91-1.37-0.39
Interest Expense0.340.24-0.000.000.000.00
Unusual Expense3.343.34-0.70-2.960.000.000.00
Net Income Before Taxes-6.23-5.85-0.970.28-1.90-1.24-0.33
Income Taxes0.000.000.000.000.000.000.00
Consolidated Net Income-6.23-5.85-0.970.28-1.90-1.24-0.33
Net Income From Continuing Operations-6.23-5.85-0.970.28-1.90-1.24-0.33
Net Income-6.23-5.85-0.970.28-1.90-1.24-0.33
EPS (Recurring)-0.13-0.12-0.05-0.06-0.07-0.09-0.01
EPS (Basic, Before Extraordinaries)-0.21-0.20-0.030.01-0.07-0.09-0.01
EPS (Diluted)-0.21-0.20-0.030.01-0.07-0.09-0.01
EBITDA-1.97-1.61-1.23-2.18-1.90-1.35-0.37
Non-Operating Income (Expense)-0.56-0.64-0.42-0.480.010.130.06
Other After Tax Adjustments0.000.000.000.000.000.000.00
Stock Option Compensation Expense0.710.420.280.260.04-0.08
Shares Outstanding30.5329.7929.7929.4528.0214.0129.45
Market Capitalization322.73217.4594.22116.01109.24--

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY
Cash & Short Term Investments5.080.871.182.10
Short Term Receivables0.000.000.000.00
Inventories0.000.000.000.00
Other Current Assets0.120.230.020.02
Total Current Assets5.201.101.202.13
Net Property, Plant & Equipment0.080.120.030.08
Total Investments and Advances0.000.000.000.00
Long-Term Note Receivable1.07---
Intangible Assets0.920.820.770.70
Deferred Tax Assets0.120.070.10-
Other Assets5.970.010.010.01
Total Assets13.352.122.112.91
Short Term Debt Incl. Current Port. of LT Debt0.050.040.030.05
Accounts Payable2.930.670.460.26
Other Current Liabilities3.030.000.001.42
Total Current Liabilities6.000.710.491.72
Long Term Debt0.030.080.000.03
Provision for Risks Charges0.000.000.000.00
Deferred Tax Liabilities0.120.070.10-
Other Liabilities1.441.441.440.00
Total Liabilities7.602.292.031.76
Non-Equity Reserves0.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.00
Common Equity5.76-0.180.091.16
Total Shareholders Equity5.76-0.180.091.16
Accumulated Minority Interest0.000.000.000.00
Total Equity5.76-0.180.091.16
Total Liabilities & Stockholders Equity13.352.122.112.91
Book Value Per Share0.20-0.010.010.09
Tangible Book Value Per Share0.16-0.07-0.050.03
Full-Time Employees2---
Price to Book Ratio56.70186.71--
Return on Assets-41.30-87.36-91.20-
Return on Equity-114.50--369.43-
Return on Invested Capital-55.16--2,672.64-360.42
Quick Ratio0.871.552.451.23
Current Ratio0.871.552.451.23

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY
Net Income-12.77-3.19-1.77-2.29-4.29
Depreciation0.060.050.050.040.05
Other Funds (Non Cash)7.20-1.790.360.641.93
Funds from Operations-5.51-4.93-1.36-1.61-2.31
Extraordinary Item0.000.000.000.000.00
Changes in Working Capital0.232.37-0.000.231.07
Cash from Operating Activities-5.28-2.56-1.36-1.38-1.24
Capital Expenditures-0.07-0.15-0.10-0.04-0.02
Net Assets From Acquisitions0.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.00
Purchase of Investments0.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.00
Other Uses0.000.000.000.000.00
Other Sources0.000.000.000.000.00
Cash from Investing Activities-0.07-0.15-0.10-0.04-0.02
Cash Dividends Paid0.000.000.000.000.00
Change in Capital Stock4.826.921.150.500.35
Repurchase of Common Pref Stock0.000.000.000.000.00
Sale of Common Pref Stock4.826.921.150.500.35
Proceedsfrom Stock Options4.826.921.150.500.35
Issuance or Reduction of Debt, Net6.720.000.000.000.00
Change in Long Term Debt6.720.000.000.000.00
Issuance of Long Term Debt6.720.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.00
Net Financing Active Other Cash Flow1.070.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.00
Cash from Financing Activities12.616.921.150.500.35
Net Change in Cash7.264.20-0.31-0.92-0.91
Free Cash Flow-5.28-2.56-1.36-1.38-1.24
Preferred Dividends (Cash Flow)-0.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments10.3610.2911.225.083.113.19
Short Term Receivables0.000.000.000.000.000.00
Inventories0.000.000.000.000.000.00
Other Current Assets0.100.140.240.120.190.20
Total Current Assets10.4710.4311.455.203.293.39
Net Property, Plant & Equipment0.040.060.070.080.090.10
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets0.910.910.920.920.900.83
Deferred Tax Assets---0.12--
Other Assets4.925.576.205.970.010.01
Total Assets16.3516.9618.6413.354.354.98
Short Term Debt Incl. Current Port. of LT Debt0.490.050.050.050.040.04
Accounts Payable2.422.612.322.932.261.02
Other Current Liabilities0.576.112.773.030.00-0.00
Total Current Liabilities3.488.765.136.002.311.06
Long Term Debt5.746.075.960.030.050.06
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---0.12--
Other Liabilities1.441.441.441.441.441.44
Total Liabilities10.6616.2712.537.603.792.56
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity5.690.696.125.760.562.42
Total Shareholders Equity5.690.696.125.760.562.42
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity5.690.696.125.760.562.42
Total Liabilities & Stockholders Equity16.3516.9618.6413.354.354.98
Book Value Per Share0.190.020.210.200.020.17
Tangible Book Value Per Share0.16-0.010.170.16-0.010.11
Full-Time Employees---2--
Price to Book Ratio56.7035.5516.37198.29186.71-
Return on Assets-123.41-76.99----
Return on Equity-408.79-543.37----
Return on Invested Capital-54.50-86.55-8.044.82-315.75-50.02
Quick Ratio3.011.192.230.871.433.20
Current Ratio3.011.192.230.871.433.20

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-6.23-5.85-0.970.28-1.90-1.24
Depreciation0.010.010.010.010.010.01
Other Funds (Non Cash)4.834.520.06-2.200.040.05
Funds from Operations-1.39-1.32-0.90-1.91-1.85-1.18
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.160.39-0.740.731.260.68
Cash from Operating Activities-1.55-0.92-1.63-1.18-0.59-0.50
Capital Expenditures-0.02-0.01-0.01-0.03-0.09-0.03
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.02-0.01-0.01-0.03-0.09-0.03
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock1.640.000.003.180.592.15
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock1.640.000.003.180.592.15
Proceedsfrom Stock Options1.640.000.003.180.592.15
Issuance or Reduction of Debt, Net-2E-061E-066.720.000.000.00
Change in Long Term Debt-2E-061E-066.720.000.000.00
Issuance of Long Term Debt-2E-061E-066.720.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.001.070.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities1.641E-067.793.180.592.15
Net Change in Cash0.08-0.936.141.97-0.081.62
Free Cash Flow-1.55-0.92-1.63-1.18-0.59-0.50

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-304.80%0.5M11.1M105.99K
2026-10-153.90%0.4M11.1M106.67K
2026-09-302.49%0.3M10.8M117.37K
2026-09-151.43%0.2M10.8M90.15K
2026-08-311.23%0.1M10.8M79.96K
2026-08-141.06%0.1M10.8M84.07K
2026-07-310.78%0.1M10.8M78.14K
2026-07-150.54%0.1M10.8M65.26K
2026-06-300.36%0.0M10.8M42.82K
2026-06-150.28%0.0M10.8M39.21K
2026-05-290.59%0.1M10.8M30.01K
2026-05-150.60%0.1M10.8M22.81K
2026-04-300.49%0.1M10.6M22.76K
2026-04-150.57%0.1M10.6M25.98K
2026-03-310.60%0.1M10.6M30.78K
2026-03-130.63%0.1M10.5M41.33K
2026-02-270.68%0.1M10.5M48.61K
2026-02-130.74%0.1M10.5M66.41K
2026-01-300.78%0.1M10.5M75.43K
2026-01-150.67%0.1M10.5M99.18K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.506.0010.000.0020.0250.000.000.978-0.0960.001
call5.003.507.500.009.8090.000.000.921-0.1860.002
call7.501.004.900.005.9780.000.000.821-0.2070.004
call10.000.004.000.005.6090.000.000.720-0.2030.006
call12.500.003.200.005.9270.000.000.610-0.2120.006
call15.000.003.100.106.6541.000.000.572-0.2430.006
call17.500.000.950.003.9580.000.000.305-0.1290.006
call20.000.000.750.007.8340.000.000.530-0.2760.006
call22.500.002.950.004.5110.000.000.235-0.1290.005
call25.000.002.950.004.8650.000.000.225-0.1360.005
put2.500.002.950.000.0000.000.00-0.022-0.0960.001
put5.000.002.950.0013.5640.000.00-0.079-0.1860.002
put7.500.003.100.758.6661.000.00-0.176-0.2080.004
put10.000.003.600.006.6960.000.00-0.279-0.2050.006
put12.500.104.900.005.5860.000.00-0.390-0.2110.006
put15.002.506.500.005.0980.000.00-0.428-0.2420.006
put17.505.009.000.005.7780.000.00-0.695-0.1270.006
put20.007.5011.500.006.3940.000.00-0.752-0.1180.005
put22.5010.0014.000.006.7770.000.00-0.765-0.1270.005
put25.0012.5016.500.007.1660.000.00-0.775-0.1330.005

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-108-KCurrent report2026-11-10SEC
2026-11-09S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-11-09S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-11-0910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-098-KCurrent report2026-11-09SEC
2026-10-19ARSAnnual report to security holders. 2025-12-31SEC
2026-10-19DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-11-30SEC
2026-10-078-KCurrent report2026-10-06SEC
2026-09-108-KCurrent report2026-09-10SEC
2026-09-098-KCurrent report2026-09-09SEC
2026-08-26DNotice of sales of securities on Form D (Regulation D)SEC
2026-08-188-KCurrent report2026-08-13SEC
2026-08-178-KCurrent report2026-08-14SEC
2026-08-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-128-KCurrent report2026-08-12SEC
2026-07-288-KCurrent report2026-07-28SEC
2026-07-078-KCurrent report2026-07-07SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-04SEC
2026-06-038-KCurrent report2026-06-03SEC
2026-06-014Statement of changes in beneficial ownership of securities2026-05-28SEC
2026-06-018-KCurrent report2026-06-01SEC
2026-05-278-KCurrent report2026-05-27SEC
2026-05-198-KCurrent report2026-05-19SEC
2026-05-188-KCurrent report2026-05-18SEC
2026-05-13C-TRTermination of ReportingSEC
2026-05-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-118-KCurrent report2026-05-11SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-128.75K100
2025-11109.00K500

Institutional holders

Manager% owned
SteelPeak Wealth, LLC0.84%
IEQ CAPITAL, LLC0.76%
GEODE CAPITAL MANAGEMENT, LLC0.53%
DDFG, Inc0.37%
VANGUARD CAPITAL MANAGEMENT LLC0.25%
Wellington Shields & Co., LLC0.22%
MILLENNIUM MANAGEMENT LLC0.20%
BlackRock, Inc.0.13%
Aaron Wealth Advisors LLC0.11%
Tamar Securities, LLC0.10%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND0.21%
iShares Micro-Cap ETF0.12%
Fidelity Nasdaq Composite Index Fund0.06%
VANGUARD BALANCED INDEX FUND0.03%
1290 VT Micro Cap Portfolio0.01%
Victory Extended Market Index Fund0.00%
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND0.00%

OakChart. TTRX. Cached 15 minutes.